CNR1 and central nervous system cancer: Gliomas have been shown to possess one or more components of the endocannabinoid system such as the ability to synthesize endocannabinoids, the presence of CB1/CB2 receptors and the enzyme FAAH, thus suggesting a possible role of this system in regulation of cell growth.